DDL, Inc. announced today it is now offering testing based on ISO 11608-1, the governing standard that specifies general requirements and test methods for needle-based injection systems. These new capabilities supplement DDL’s already extensive expertise in syringe, needle and combination product testing.
“Many new drugs and biologics coming to market today are well suited for administration via needle-based injection systems or auto injectors,” said Levi Loesch, Product and Materials Engineer, DDL, Inc. “DDL is now able to perform the testing as defined in ISO 11608-1 to ensure these devices meet the dose accuracy requirements.”
ISO 11608 is comprised of seven parts. DDL currently provides testing for ISO 11608-1 – needle-based injection systems intended to be used with needles and with replaceable or non-replaceable containers. DDL is actively working to add additional parts of the 11608 standard to its list of core tests.
Please contact us for more information on DDL’s ISO 11608 testing capabilities.